Skip to main content
Skip to main content
BIOX logo

Bioceres Crop Solutions Corp. (BIOX) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.4225 -$0.0039 (-0.91%) |Weak · 38
Bioceres Crop Solutions Corp. (BIOX) bottom line: signals are mixed — the Council read leans Split View (43/100) while the AI fundamental score is 38/100 (grade D); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Izzy Englander bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $26.7M| Vol: 66.7K| Target: $8.00 (+1793.5%) (Aug 25, 2026) (estimate, not advice)| 52-wk range: $0.301 – $2.29

Market cap $26.7M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Bioceres Crop Solutions Corp. (BIOX) trades at $0.4225 with MoonshotScore 38/100 (Grade D). Bioceres Crop Solutions Corp. provides crop productivity solutions through seed and integrated products, crop protection, and crop nutrition. Market cap: $26.7M, Sector: Basic materials.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
Bioceres Crop Solutions Corp. provides crop productivity solutions through seed and integrated products, crop protection, and crop nutrition. The company operates internationally, focusing on developing and commercializing technologies for enhanced agricultural outcomes.

BIOX stock analysis for 2026: Analysts have set a consensus price target of $8.00 for Bioceres Crop Solutions Corp., suggesting 1793.5% upside from the current price of $0.42. The AI MoonshotScore is 38/100, in the Weak band (below 45) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the BIOX film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 43/100 · C

BIOX: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 38/100
Business Quality
Weak Is this a genuinely good business?
Financial Safety
Negative Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Negative Is the growth real and likely to last?
Momentum
Negative Is the market already moving on this?

Strongest side: Valuation (9/10, Strong). Weakest side: Growth Durability (1/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Bioceres Crop Solutions Corp. (BIOX) Materials & Commodity Exposure

CEOFederico Trucco
Employees751
HeadquartersRosario, AR
IPO Year2018

Bioceres Crop Solutions Corp. delivers crop productivity solutions across seed technology, crop protection, and nutrition, operating in Argentina, Uruguay, France, South Africa, and other international markets. The company's focus on biotechnological events and drought-tolerant seed programs like HB4 positions it within the agricultural inputs sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for BIOX?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

The company's HB4 drought-tolerant seed technology offers a significant value proposition in regions facing water scarcity. Key value drivers include the expansion of HB4 technology adoption and the growth of its crop protection and nutrition segments. With a market capitalization of $26.7M, Bioceres operates with a gross margin of 37.1%. However, the company's negative profit margin of -82.8% indicates ongoing challenges in achieving profitability. Future growth hinges on successful commercialization of its technologies and effective cost management. Investors should monitor the company's ability to improve profitability and expand its market share in key regions.

Based on FMP financials and quantitative analysis

BIOX Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $26.7M reflects its current valuation in the agricultural solutions market.

  • Gross margin of 37.1% indicates the company's ability to generate revenue from its products and services.
  • HB4 drought-tolerant seed technology offers a potential competitive advantage in water-stressed regions.
  • Operations in Argentina, Uruguay, France, and South Africa provide geographic diversification.
  • Negative profit margin of -82.8% highlights the need for improved cost management and profitability.

Who Are BIOX's Competitors?

BIOX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BAYRY Bayer AG $14.07 -1.54% $55.3B 519-signal
SYT SYLA Technologies Co., Ltd. American Depositary Shares $2.26 0.00%
CTVA Corteva, Inc. $84.47 -0.33% $56.5B 715-pillar
BHST BioHarvest Sciences Inc. $1.85 -1.07% $32.1M
ARLSF Argo Graphene Solutions Corp. $0.70 +0.78% $17.7M 449-signal
SEED Origin Agritech Limited $1.05 +3.96% $12.7M
AVD American Vanguard Corporation $2.24 +0.45% $64.1M 365-pillar
AGRZ Agroz Inc. $0.24 -5.38% $5.14M 505-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are BIOX's Key Strengths?

Innovative HB4 drought-tolerant technology.

  • Diversified product portfolio across seed, crop protection, and nutrition.
  • International presence in key agricultural markets.
  • Focus on sustainable agricultural practices.

What Are BIOX's Weaknesses?

Negative profit margin.

  • Relatively small market capitalization.
  • Dependence on specific technologies and markets.
  • Limited brand recognition compared to larger competitors.

What Could Drive BIOX Stock Higher?

Expansion of HB4 technology adoption in key agricultural regions.

  • Growth in the biological crop protection and nutrition segments.
  • Potential strategic partnerships and acquisitions to expand market reach.
  • Development and commercialization of new sustainable agricultural solutions.

What Are the Key Risks for BIOX?

Listing risk — at $0.4225 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.

  • Financial-distress signal — its Altman Z-Score of 0.20 sits in the distress zone (elevated bankruptcy risk).
  • Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
  • Competition from larger, more established players in the agricultural inputs industry.
  • Regulatory changes and environmental concerns affecting the use of certain crop protection products.
  • Fluctuations in commodity prices and weather patterns impacting crop yields and demand.
  • Economic and political instability in key markets, particularly in Argentina.

What Are the Growth Opportunities for BIOX?

  • Expansion of HB4 Technology: The HB4 drought-tolerant seed technology represents a significant growth opportunity for Bioceres. As climate change intensifies and water scarcity becomes more prevalent, the demand for drought-resistant crops is expected to increase. The company can leverage this trend by expanding the adoption of HB4 technology in key markets, particularly in regions prone to drought. Timeline: Ongoing.
  • Growth in Crop Protection Segment: The Crop Protection segment offers growth potential through the development and commercialization of innovative and sustainable crop protection products. With increasing concerns about the environmental impact of traditional pesticides, there is a growing demand for biological and eco-friendly alternatives. Bioceres can capitalize on this trend by expanding its portfolio of Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The global market for biological crop protection is expected to grow significantly, providing opportunities for Bioceres to increase its market share. Timeline: Ongoing.
  • Development of Crop Nutrition Segment: Bioceres has the opportunity to further develop its Crop Nutrition segment by focusing on inoculants, bio-inductors, and biological and microgranulated fertilizers. These products can enhance crop yields and improve soil health, aligning with the growing demand for sustainable agricultural practices. The company can expand its market presence by offering customized solutions tailored to specific crop and soil conditions. The global market for biological fertilizers is experiencing rapid growth, driven by the need to reduce reliance on synthetic fertilizers and promote environmental sustainability. Timeline: Ongoing.
  • Geographic Expansion: Bioceres can pursue growth through geographic expansion into new markets. While the company already operates in Argentina, Uruguay, France, and South Africa, there are opportunities to expand its presence in other regions with significant agricultural activity. This can be achieved through strategic partnerships, acquisitions, or direct investment. Expanding into new markets can diversify the company's revenue streams and reduce its reliance on specific regions. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Bioceres can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the agricultural sector can provide access to new technologies, markets, and distribution channels. Acquiring complementary businesses can expand the company's product portfolio and strengthen its competitive position. Strategic partnerships and acquisitions can enhance Bioceres's ability to innovate and deliver comprehensive solutions to its customers. Timeline: Ongoing.

What Are BIOX's Competitive Advantages?

  • Proprietary HB4 drought-tolerant technology.
  • Established presence in key agricultural markets.
  • Integrated approach to crop productivity solutions.
  • Focus on sustainable agricultural practices.

What Does BIOX Do?

Founded in 2001 and headquartered in Rosario, Argentina, Bioceres Crop Solutions Corp. has evolved into a provider of comprehensive crop productivity solutions. Originally conceived as a network of agricultural entrepreneurs, Bioceres transitioned into a publicly listed company focused on developing and commercializing agricultural technologies. The company operates through three primary segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment focuses on seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops and markets a range of products, including Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment offers inoculants, bio-inductors, and biological and microgranulated fertilizers. A key offering is HB4, a drought-tolerant seed technology program designed to enhance crop yields under water stress conditions. Bioceres operates in Argentina, Uruguay, France, South Africa, and other international markets, positioning itself as a global player in agricultural solutions.

What Products and Services Does BIOX Offer?

  • Develop and commercialize seed technology and biotechnological events.
  • Produce and market crop protection products, including herbicides and insecticides.
  • Offer crop nutrition solutions such as inoculants and bio-inductors.
  • Provide drought-tolerant seed technology through the HB4 program.
  • Operate in Argentina, Uruguay, France, South Africa, and internationally.
  • Focus on sustainable agricultural practices and solutions.
  • Develop germplasm and seed treatments.

How Does BIOX Make Money?

  • Develop and sell seed and integrated products.
  • Manufacture and distribute crop protection products.
  • Produce and market crop nutrition solutions.
  • Generate revenue through the sale of HB4 drought-tolerant seeds.

What Industry Does BIOX Operate In?

Bioceres Crop Solutions Corp. operates within the agricultural inputs industry, which is characterized by increasing demand for sustainable and efficient farming practices. The global market for agricultural inputs is driven by the need to enhance crop yields and improve food security. Key trends include the adoption of biotechnological solutions, precision agriculture, and biological crop protection products. Bioceres competes with established players in the seed, crop protection, and nutrition segments, differentiating itself through innovative technologies like HB4 and a focus on sustainable solutions. The industry is subject to regulatory oversight and is influenced by factors such as commodity prices, weather patterns, and government policies.

Who Are BIOX's Key Customers?

  • Farmers and agricultural producers.
  • Seed companies and distributors.
  • Agricultural cooperatives.
  • Governmental and non-governmental organizations.
Model self-rating on this text: 72% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 89/100

Broad, current evidence sits behind this analysis.

  • Scored on 94% of our measures
  • Price is current
  • Latest filing 122 days ago
  • Covered by analysts

Why 38?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Free cash flow yield (Business Quality)
  • +0.54 Enterprise value vs free cash flow (Valuation)
  • +0.54 Price to book (Valuation)

What is holding it back

  • -0.78 Return on assets (Business Quality)
  • -0.78 Net margin (Business Quality)
  • -0.65 Return on equity (Business Quality)

Risk penalties applied

  • -0.81 Bankruptcy-risk score in the distress zone

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 42
2026-08-26 42
2026-08-29 42
2026-09-01 40
2026-09-04 39
2026-09-07 37
2026-09-10 38

What changed?

The grade moved from 42 to 38 (-4).

Over the same 18 days the stock moved -3.3%.

Company Profile

Bioceres Crop Solutions Corp. operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Rosario, AR. The company is led by CEO Federico Trucco. BIOX has traded publicly since 2018.

Bioceres Crop Solutions Corp. Financial Trajectory

Bioceres Crop Solutions Corp. (BIOX) reported $38.2M in revenue for Q3 FY2026, a decline of 48.2% compared to the prior quarter. The company recorded a net loss of $12.3M, with diluted EPS of $-0.19. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Basic Materials stock should monitor closely. Across the four most recent quarters, BIOX averaged $-0.97 in diluted EPS.

How Bioceres Crop Solutions Corp. Is Valued

Bioceres Crop Solutions Corp. carries a market capitalization of $26.7M, placing it in the micro-cap category. Analyst price targets span from $2.00 to $15.00, with a consensus of $8.00. At the current price of $0.42, that implies approximately 1793% upside potential. Relative to its peer group, BIOX's quantitative score of 38/100 is below the peer average of 50/100.

Key Financial Metrics

Return on assets is -46.7%, showing how much profit it generates from its asset base. A current ratio of 0.88 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9

Financial Health

Bioceres Crop Solutions Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.20 places it in the distress zone, a signal of elevated financial risk.

1/8 beats

Earnings Track Record

Bioceres Crop Solutions Corp. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 295.3% below estimates on average.

Net buying

Insider Activity

Over the past six months, Bioceres Crop Solutions Corp. insiders filed 3 SEC Form 4 transactions — 2 sales and 1 purchases. On net that is roughly 95K shares acquired (about $544K) — insiders putting money in tends to read as conviction.

BIOX Financials

Fundamental Snapshot

Revenue Growth (FY)
-28.3%
Free Cash Flow Growth (FY)
+86.4%
Return on Equity (TTM)
-151.3%
Current Ratio
0.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Innovative HB4 drought-tolerant technology.
  • Diversified product portfolio across seed, crop protection, and nutrition.
  • International presence in key agricultural markets.
  • Focus on sustainable agricultural practices.

Bear Case

  • Negative profit margin.
  • Relatively small market capitalization.
  • Dependence on specific technologies and markets.
  • Limited brand recognition compared to larger competitors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 FY2026 $38M -$12M -$0.19
Q2 FY2026 $74M -$183M -$2.88
Q1 FY2026 $77M -$7M -$0.12
Q4 FY2025 $74M -$48M -$0.70

Q3 FY2026 · filed 12 May 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

BIOX Latest News

BIOX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BIOX.

Price Targets

Low
$2.00
Consensus
$8.00
High
$15.00

Median: $5.00 (+1793.5% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

BIOX MoonshotScore

38/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. BIOX scores 38/100 (Grade D): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Federico Trucco

CEO

Federico Trucco has served as the CEO of Bioceres Crop Solutions Corp. since its inception. He has a strong background in agricultural biotechnology and business management. Prior to Bioceres, he held various leadership positions in the agricultural sector. Trucco holds a Ph.D. in Crop Sciences from the University of Illinois at Urbana-Champaign and an MBA from the Kellogg School of Management at Northwestern University.

Track Record: Under Federico Trucco's leadership, Bioceres has transformed from a network of agricultural entrepreneurs into a publicly listed company. He has overseen the development and commercialization of key technologies, including the HB4 drought-tolerant seed program. Trucco has also led the company's expansion into new markets and the diversification of its product portfolio. His strategic decisions have positioned Bioceres as a player in the agricultural solutions market.

BIOX Basic Materials Stock FAQ

What does the AI Score mean for BIOX?

BIOX holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Bioceres Crop Solutions Corp. provides crop productivity solutions through seed and integrated products, crop protection, and crop nutrition.

Is BIOX a good stock?

Stock Expert AI does not rate BIOX buy, sell or hold. Bioceres Crop Solutions Corp. carries a MoonshotScore of 38/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What does Bioceres Crop Solutions Corp. do?

Bioceres Crop Solutions Corp. provides crop productivity solutions through its Seed and Integrated Products, Crop Protection, and Crop Nutrition segments.

What are the key factors to evaluate for BIOX?

Bioceres Crop Solutions Corp. (BIOX) holds a MoonshotScore of 38/100 (low). Analysts target $8.00 (+1793%). Key value drivers include the expansion of HB4 technology adoption and the growth of its crop protection and nutrition segments. Not financial advice.

How frequently does BIOX data refresh on this page?

BIOX's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven BIOX's recent stock price performance?

Bioceres Crop Solutions Corp. (BIOX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative HB4 drought-tolerant technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BIOX overvalued or undervalued right now?

Bioceres Crop Solutions Corp. (BIOX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $8.00 (+1793%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of BIOX?

Yes, most major brokerages offer fractional shares of Bioceres Crop Solutions Corp. (BIOX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track BIOX's earnings and financial reports?

Bioceres Crop Solutions Corp. (BIOX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BIOX earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available company data and may be subject to change.
  • Financial metrics are based on the most recent available data.
  • Analyst opinions may vary.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover